BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,447,000 | -59.6% | 29,416 | -61.0% | 0.00% | -66.7% |
| Q2 2022 | $11,002,000 | -37.3% | 75,513 | -49.0% | 0.00% | -25.0% |
| Q1 2022 | $17,541,000 | -43.5% | 147,932 | -34.4% | 0.00% | -42.9% |
| Q4 2021 | $31,058,000 | +53.2% | 225,365 | +54.4% | 0.01% | +40.0% |
| Q3 2021 | $20,276,000 | +161.7% | 145,961 | +82.9% | 0.01% | +150.0% |
| Q2 2021 | $7,748,000 | +774.5% | 79,807 | +515.7% | 0.00% | – |
| Q1 2021 | $886,000 | -0.2% | 12,962 | +25.1% | 0.00% | – |
| Q4 2020 | $888,000 | +309.2% | 10,358 | +211.2% | 0.00% | – |
| Q3 2020 | $217,000 | -81.0% | 3,328 | -78.7% | 0.00% | – |
| Q2 2020 | $1,142,000 | -91.7% | 15,630 | -93.8% | 0.00% | -100.0% |
| Q4 2019 | $13,756,000 | +26.3% | 252,670 | -3.2% | 0.00% | +33.3% |
| Q3 2019 | $10,895,000 | +18.8% | 261,139 | +24.7% | 0.00% | +50.0% |
| Q2 2019 | $9,171,000 | -5.8% | 209,433 | +10.7% | 0.00% | -33.3% |
| Q1 2019 | $9,734,000 | +25.9% | 189,121 | -9.5% | 0.00% | 0.0% |
| Q4 2018 | $7,730,000 | +933.4% | 209,041 | +654.0% | 0.00% | – |
| Q4 2017 | $748,000 | – | 27,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |